Fundraising often reflects progress, it doesn't define it. Michael Rhys (CEO) shares how Barnwell Bio has prioritised producer feedback, early customer validation, and real-world data generation to drive focus, support partnerships, and set the foundation for long-term scale.
Michael Rhys
Chief Executive Officer & Co-Founder
Barnwell Bio
Placing the pet owner and their companions at the center of the entire animal health value chain, how do we design a future where everyone in this ecosystem wins? We’ll discuss…
- The full spectrum of information that helps define prevalence of disease and wellness needs
- Pet owners' need for convenience, transparency and accessibility
- How data unlocks accessibility, affordability, personalization and prediction
- In order for this vision to happen, what are the roadblocks we need to overcome?
Moderator
Rimma Driscoll
Executive Vice President, Global Strategy, Portfolio Marketing and Business Development, Global BioDevices and Platinum Performance
Zoetis
Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.
Panelist
Jay Price
Chief Executive Officer
Mission Pet Health
Matthew Salois
President
Veterinary Management Groups (VMG)
Fundraising often reflects progress, it doesn't define it. Michael Rhys (CEO) shares how Barnwell Bio has prioritised producer feedback, early customer validation, and real-world data generation to drive focus, support partnerships, and set the foundation for long-term scale.
Michael Rhys
Chief Executive Officer & Co-Founder
Barnwell Bio
Approval alone doesn’t guarantee commercial success. Robert Jordan shares how Vetirus Pharmaceuticals combines in-house regulatory expertise with early manufacturing planning, ensuring supply, shortening timelines to revenue, and enabling global expansion.
Robert Jordan
Chief Executive Officer
Vetirus Pharmaceuticals